Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019_ randomised controlled trial Auteur/autrice de la publication :Admin Post published:23 janvier 2021 Post category:COVID 19 Effect-of-tocilizumab-on-clinical-outcomes-at-15-days-in-patients-with-severe-or-critical-coronavirus-disease-2019_-randomised-controlled-trialTélécharger Vous devriez également aimer Asthma and allergic diseases are not risk factors for hospitalization in children with 27 janvier 2021 COVID-19_ A Review for the Pediatric Neurologist 16 décembre 2020 Diagnostic Accuracy of the Panbio SARS-CoV-2 Antigen Rapid Test Compared with Rt-Pcr Testing of Nasopharyngeal Samples in the Pediatric Population 25 janvier 2021
Asthma and allergic diseases are not risk factors for hospitalization in children with 27 janvier 2021
Diagnostic Accuracy of the Panbio SARS-CoV-2 Antigen Rapid Test Compared with Rt-Pcr Testing of Nasopharyngeal Samples in the Pediatric Population 25 janvier 2021